Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial

BE0000573ProteinHumansACADSB

Short and branched chain specific acyl-CoA dehydrogenase that catalyzes the proR-proR stereospecific alpha,beta-dehydrogenation of fatty acyl-CoA thioesters using the electron transfer flavoprotein (ETF) as their physiologic electron acceptor, resulting in the formation of trans-2-enoyl-CoA ((2E)-enoyl-CoA)... It is acted on by 2 drugs in DrugBank.

Gene name
ACADSB
UniProtKB entry
P45954Swiss-Prot
Cellular location
Mitochondrion matrix
Residues / weight
432 residues · 47,485 Da
Also known as
1.3.8.1 · 2-MEBCAD · 2-methyl branched chain acyl-CoA dehydrogenase · 2-methylbutyryl-CoA dehydrogenase · 2-methylbutyryl-coenzyme A dehydrogenase

Resolves to

Pharmacology
Structure

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
17+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial, how selective are they, and which programs against it are still in active trials?

Create a free account or log in to explore the full data card.

Create Account